Litcius/Paper detail

Effectiveness and tolerance of Janus kinase inhibitors for the treatment of recalcitrant atopic dermatitis in a real-life French multicenter adult cohort

Julia Vanlerberghe, F. Dezoteux, Claire Martin, M. Jachiet, Angèle Soria, F. Tétart, Anne-Bénédicte Modeste-Duval, A.‐C. Bursztejn, L. Misery, F. Aubin, A. Lasek, C. Leleu, A. Du‐Thanh, Justine Pasteur, P. Pralong, Audrey Nosbaum, C. Droitcourt, M. Viguier, M. Tauber, Julien Sénéschal, S. Barbarot, D. Staumont‐Sallé

2022Journal of the American Academy of Dermatology17 citationsDOIOpen Access PDF

Topics & Concepts

MedicineAtopic dermatitisCohort studyCohortDermatologyJanus kinaseJanusMulticenter studyInternal medicineRandomized controlled trialNanotechnologyCytokineMaterials scienceDermatology and Skin DiseasesAllergic Rhinitis and SensitizationFood Allergy and Anaphylaxis Research
Effectiveness and tolerance of Janus kinase inhibitors for the treatment of recalcitrant atopic dermatitis in a real-life French multicenter adult cohort | Litcius